β1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 3499315)

Published in Cell Adh Migr on March 01, 2012

Authors

Grant A Howe1, Christina L Addison

Author Affiliations

1: Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON Canada.

Articles cited by this

Integrins: bidirectional, allosteric signaling machines. Cell (2002) 36.25

Integrins: versatility, modulation, and signaling in cell adhesion. Cell (1992) 34.06

The extracellular matrix: not just pretty fibrils. Science (2009) 8.52

Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol (2006) 8.52

Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods (2007) 7.43

Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science (2010) 6.67

Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature (1996) 6.02

Signaling through focal adhesion kinase. Prog Biophys Mol Biol (1999) 5.33

Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell (2004) 4.34

Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev Cell (2007) 3.84

Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res (2008) 3.11

Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer (2010) 2.94

Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med (1999) 2.92

Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen (2009) 2.83

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol (2010) 2.75

Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci U S A (2007) 2.64

The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol Cell Biol (1999) 2.56

Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol (2011) 2.48

A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. J Med Chem (2008) 2.31

Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. Proc Natl Acad Sci U S A (2004) 2.25

Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr Opin Cell Biol (1997) 1.97

Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene (2001) 1.96

Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer Res (2007) 1.90

The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev (1995) 1.84

Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Res (2008) 1.83

A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer. Cell Cycle (2009) 1.79

Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors. J Natl Cancer Inst (2000) 1.77

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Mol Carcinog (2007) 1.74

The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer (2000) 1.71

Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells. Nat Biotechnol (2010) 1.66

Involvement of extracellular matrix constituents in breast cancer. Semin Cancer Biol (1995) 1.57

Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol (1994) 1.57

Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol (2007) 1.53

Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol (1995) 1.49

3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal (2011) 1.47

Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models. Cancer Biol Ther (2010) 1.41

beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene (2006) 1.41

Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis (1999) 1.41

beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression. Proc Natl Acad Sci U S A (2010) 1.40

Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood (1999) 1.37

Cell-extracellular matrix interactions in normal and diseased skin. Cold Spring Harb Perspect Biol (2011) 1.37

Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int J Cancer (2003) 1.35

Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines. J Cancer Res Clin Oncol (1993) 1.35

Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci (1996) 1.31

Integrin activation and internalization on soft ECM as a mechanism of induction of stem cell differentiation by ECM elasticity. Proc Natl Acad Sci U S A (2011) 1.31

Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res (2006) 1.31

Integrin-linked kinase and PINCH: partners in regulation of cell-extracellular matrix interaction and signal transduction. J Cell Sci (1999) 1.30

ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase. Cell Death Differ (2006) 1.30

Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res (2003) 1.29

The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis. Crit Rev Clin Lab Sci (2008) 1.28

Association of beta 1 integrin with focal adhesion kinase and paxillin in differentiating Schwann cells. J Neurosci (2000) 1.26

Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells. Blood (2001) 1.26

Integrin-linked kinase: not so 'pseudo' after all. Oncogene (2011) 1.24

Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. Cancer Res (2005) 1.22

Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. Eur J Cancer (1997) 1.21

Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models. PLoS Genet (2011) 1.20

Ionizing radiation induces up-regulation of functional beta1-integrin in human lung tumour cell lines in vitro. Int J Radiat Biol (2002) 1.15

Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life (2010) 1.12

Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. Am J Pathol (1996) 1.12

Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells. Hepatology (1999) 1.10

Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-beta in invasive carcinomas (Review). Int J Oncol (2001) 1.09

CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol Biol Cell (1996) 1.07

Mechanosensing machinery for cells under low substratum rigidity. Am J Physiol Cell Physiol (2008) 1.02

Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin Sci (Lond) (2002) 1.01

Loss of basement membrane components laminin and type IV collagen parallels the progression of oral epithelial neoplasia. Histopathology (1998) 1.00

Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro. Br J Cancer (2003) 0.99

Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK). Mol Cancer Ther (2008) 0.98

Association between integrin expression and prognosis in localized prostate cancer. Prostate (2010) 0.97

An alpha5beta1 integrin inhibitor attenuates glioma growth. Mol Cell Neurosci (2008) 0.97

Stimulation of glioma-cell migration by laminin and inhibition by anti-alpha3 and anti-beta1 integrin antibodies. Int J Cancer (1996) 0.96

The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth. Mol Cancer Ther (2007) 0.95

Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer (1996) 0.95

Radiobiology goes 3D: how ECM and cell morphology impact on cell survival after irradiation. Radiother Oncol (2011) 0.94

AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients. Gynecol Oncol (2003) 0.94

Beta1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1. J Cell Physiol (2010) 0.93

Changes in matrix composition during the growth and regression of human hemangiomas. J Surg Res (1998) 0.93

Integrin alpha 2 beta 1 in tumorigenic human osteosarcoma cell lines regulates cell adhesion, migration, and invasion by interaction with type I collagen. Cell Growth Differ (1996) 0.93

Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen. Invasion Metastasis (1998) 0.92

Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways. Biochimie (2010) 0.92

The role of beta 1 integrins in tumors. Semin Cancer Biol (1993) 0.91

Fibronectin in human prostatic cells in vivo and in vitro: expression, distribution, and pathological significance. Histochem Cell Biol (1999) 0.91

Selective and uncoupled role of substrate elasticity in the regulation of replication and transcription in epithelial cells. J Cell Sci (2010) 0.91

Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity. Tumour Biol (2010) 0.89

Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer (1998) 0.89

Expression level of integrin alpha 5 on tumour cells affects the rate of metastasis to the kidney. Br J Cancer (2003) 0.89

Role of the extracellular matrix in prostate carcinogenesis. J Cell Biochem (2004) 0.88

An in vitro correlation of metastatic capacity, substrate rigidity, and ECM composition. J Cell Biochem (2011) 0.86

Overview: structural biology of integrins. Methods Mol Biol (2012) 0.85

β1 integrin is required for anchorage-independent growth and invasion of tumor cells in a context dependent manner. Cancer Lett (2011) 0.84

Increased tenascin expression in melanocytic tumors. J Cutan Pathol (1994) 0.84

Alterations in expression of basement membrane proteins during tumour progression in oral mucosa. Histopathology (1994) 0.83

Cell-cell and cell-matrix interactions during breast cancer progression. Curr Top Pathol (1999) 0.83

The basement membrane and tumor progression in the uterine cervix. Gen Diagn Pathol (1997) 0.76

Articles by these authors

Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol Cell Biol (2006) 2.16

Comparison of a reference region model with direct measurement of an AIF in the analysis of DCE-MRI data. Magn Reson Med (2007) 1.49

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis (2011) 1.14

Focal adhesion kinase inhibitors are potent anti-angiogenic agents. Mol Oncol (2011) 1.03

miR-105 inhibits prostate tumour growth by suppressing CDK6 levels. PLoS One (2013) 0.94

Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors. PLoS One (2010) 0.84

β1 integrin is required for anchorage-independent growth and invasion of tumor cells in a context dependent manner. Cancer Lett (2011) 0.84

Adjuvant bisphosphonate treatment for breast cancer: why did something so elegant become so complicated? Breast Cancer Res Treat (2012) 0.83

Precipitation and selective extraction of human serum endogenous peptides with analysis by quadrupole time-of-flight mass spectrometry reveals posttranslational modifications and low-abundance peptides. Anal Bioanal Chem (2009) 0.82

The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix. Exp Cell Res (2006) 0.79

RhoB controls endothelial cell morphogenesis in part via negative regulation of RhoA. Vasc Cell (2012) 0.78

Essential role for the SLK protein kinase in embryogenesis and placental tissue development. Dev Dyn (2014) 0.78

Supplementation with l-carnitine does not reduce the efficacy of epirubicin treatment in breast cancer cells. Cancer Lett (2007) 0.77

The ZOOM trial: more boon than doom? Lancet Oncol (2013) 0.75

Distinct profile of vascular progenitor attachment to extracellular matrix proteins in cancer patients. Clin Invest Med (2012) 0.75